The data showed that downregulation of STC1 in CAFs significantly decreased the CAF-enhanced self-renewal ability and the CAF-enhanced resistance to sorafenib ability of HCC cells (Fig. 2B and C). Here, STC1 is linked to hepatocellular carcinoma.